Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Cuneo

79 clinical trials in Cuneo, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Cuneo at a glance
79
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

79 trials in Cuneo

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Deciphera Pharmaceuticals Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Busulfan
  • Sponsor:Fondazione Gimema Franco Mandelli Onlus
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Consorzio Oncotech
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Caspofungin
  • Sponsor:Basilea Pharmaceutica International AG Allschwil
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Medical University Of Gdansk

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Cuneo

What the registry says about research in the country

01 Hematologic Oncology

Groundbreaking trials focusing on Acute Myeloid Leukemia (AML) and various lymphomas, testing innovative combination therapies and transplantation approaches.

  • Leukemia treatments
  • Stem cell transplantation
  • Novel drug combinations

Studies evaluating targeted therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia.

02 Solid Tumors

Research examining innovative treatments for breast cancer, including trials for triple-negative and hormone-responsive subtypes.

  • Immunotherapy combinations
  • Targeted therapies
  • Maintenance treatments

Advanced studies in ovarian cancer and lung cancer, exploring novel therapeutic approaches.

03 Emerging Therapeutics

Investigating immunotherapy approaches across multiple cancer types, with focus on combination strategies.

  • Antibody therapies
  • Targeted molecules
  • Maintenance protocols

Evaluation of novel drug combinations and treatment sequences for optimal patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.